Global Lab Automation Market - Industry Trends and Forecast to 2029
- Published Date: 2022-12-22
- Report ID: 143002
- Pages: 225
-
Format:
Short Description
Global Lab Automation Market, By Product Type (Equipment, Software & Informatics, Analyzer), Automation Type (Modular Automation, Total Lab Automation), Application (Drug Discovery, Clinical Diagnostics, Genomics Solutions, Proteomics Solutions, Bio Analysis, Protein Engineering, Lyophilization, System Biology, Analytical Chemistry), End Users (Biotechnology & Pharmaceuticals, Hospitals & Laboratories, Research and Academic Institutions, and Others), Countries (U.S., Canada, Mexico, Germany, France, U.K, Italy, Spain, Netherlands, Russia, Denmark, Switzerland, Turkey, Sweden, Rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, New Zealand, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Ethiopia, UAE, and Rest of Middle East and Africa) Industry Trends and Forecast to 2029
Market Definition:
Laboratory automation is the combination of automated technologies in the laboratory to enable new and improved processes. It is used as a strategy to research, develop, optimize and capitalize on technologies in the laboratory. It is specially used for automating laboratory processes requiring minimal human input and eliminating human error. Lab automation is used with the aim of providing more efficient testing and diagnostics.
Lab automation enables researchers and technicians to efficiently and effectively produce output in less time, which is expected to drive the lab automation market. Furthermore, the rapid spread of diseases, along with new discoveries in the field of healthcare, ascend the demand for diagnoses and treatments, which is expected to fuel the lab automation market. High government and private funding for research and discovery research and the presence of major market players also contribute to the market growth.
Market Segmentation:
The global lab automation market is categorized into four notable segments such as product type, automation type, application, and end users.
On the basis of product type, the global lab automation market is segmented into equipment, software & informatics, and analyzer
On the basis of automation type, the global lab automation market is segmented into modular automation and total lab automation
On the basis of application, the global lab automation market is segmented into drug discovery, clinical diagnostics, genomic solutions, proteomic solutions, bio analysis, protein engineering, lyophilization, system biology, analytical chemistry, and others
On the basis of end users, the global lab automation market is segmented into biotechnology & pharmaceuticals, hospitals & laboratories, research and academic institutions, and others
Market Players
Some of the key market players in the global lab automation market are listed below:
Danaher
PerkinElmer Inc.
Thermo Fisher Scientific Inc.
Agilent Technologies, Inc.
QIAGEN
F. Hoffman-La Roche Ltd
Siemens Healthcare GmbH
Abbott
Aurora Biomed Inc.
BD
BIOMRIEUX
Eppendorf SE
LabVantage Solutions Inc.
LabWare
LabLynx LIMS
TABLE OF CONTENTS
1 INTRODUCTION 30
1.1 OBJECTIVES OF THE STUDY 30
1.2 MARKET DEFINITION 30
1.3 OVERVIEW OF THE GLOBAL LAB AUTOMATION MARKET 30
1.4 LIMITATIONS 32
1.5 MARKETS COVERED 32
2 MARKET SEGMENTATION 34
2.1 MARKETS COVERED 34
2.2 GEOGRAPHICAL SCOPE 35
2.3 YEARS CONSIDERED FOR THE STUDY 36
2.4 CURRENCY AND PRICING 36
2.5 DBMR TRIPOD DATA VALIDATION MODEL 37
2.6 MULTIVARIATE MODELLING 40
2.7 PRODUCT TYPE LIFELINE CURVE 40
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 41
2.9 DBMR MARKET POSITION GRID 42
2.10 MARKET END USER COVERAGE GRID 43
2.11 VENDOR SHARE ANALYSIS 44
2.12 SECONDARY SOURCES 45
2.13 ASSUMPTIONS 45
3 EXECUTIVE SUMMARY 46
4 PREMIUM INSIGHTS 48
4.1 PESTEL ANALYSIS 51
4.2 PORTERS FIVE FORCES 52
5 REGULATION 53
6 MARKET OVERVIEW 55
6.1 DRIVERS 57
6.1.1 INCREASING INVESTMENT & STRATEGIC INITIATIVES BY MARKET PLAYERS 57
6.1.2 GOVERNMENT INITIATIVES TO STRENGTHEN LABORATORY INFRASTRUCTURES 57
6.1.3 GROWING EXPENDITURE ON LAB AUTOMATION TOOLS AND EQUIPMENT 57
6.1.4 REDUCING HUMAN EFFORTS AND ELIMINATING HUMAN ERROR 58
6.2 RESTRAINTS 58
6.2.1 LIMITATION ANALYZING NOVEL COMPLEX PRODUCT 58
6.2.2 HIGH COST FOR INSTALLATION AND SETUP 58
6.2.3 UPGRADATION, MAINTENANCE, AND PERIODICAL CHECKUPS 59
6.3 OPPORTUNITIES 59
6.3.1 RISING HEALTHCARE EXPENDITURE 59
6.3.2 STRATEGIC INITIATIVES BY KEY PLAYERS 60
6.3.3 RISE IN THE NUMBER OF PHARMA COMPANIES 60
6.4 CHALLENGES 61
6.4.1 SLOW ADOPTION OF AUTOMATION AMONG SMALL AND MEDIUM SIZED LABORATORIES 61
6.4.2 LIMITED FEASIBILITY WITH TECHNOLOGY INTEGRATION IN ANALYTICAL LABS 61
7 GLOBAL LAB AUTOMATION MARKET, BY PRODUCT TYPE 62
7.1 OVERVIEW 63
7.2 EQUIPMENT 66
7.2.1 AUTOMATED WORKSTATIONS 66
7.2.1.1 AUTOMATED LIQUID HANDLING SYSTEMS 66
7.2.1.2 AUTOMATED INTEGRATED WORKSTATIONS 66
7.2.1.3 PIPETTING SYSTEMS 67
7.2.1.4 MICROPLATE WASHERS 67
7.2.1.5 REAGENT DISPENSERS 67
7.2.2 MICROPLATE READERS 67
7.2.2.1 MULTI-MODE MICROPLATE READERS 67
7.2.2.2 SINGLE-MODE MICROPLATE READERS 67
7.2.2.3 AUTOMATED NUCLEIC ACID PURIFICATION SYSTEMS 67
7.2.2.4 AUTOMATED ELISA SYSTEMS 68
7.2.3 OFF-THE-SHELF AUTOMATED WORKCELLS 68
7.2.4 ROBOTIC SYSTEMS 68
7.2.4.1 ROBOTIC ARMS 68
7.2.4.2 TRACK ROBOTS 68
7.2.5 AUTOMATE STORAGE & RETRIEVALS (ASRS) 68
7.2.6 OTHERS 68
7.3 ANALYZER 68
7.3.1 BIO CHEMISTRY ANALYZERS 69
7.3.2 HAEMATOLOGY ANALYZERS 69
7.3.3 IMMUNO-BASED ANALYZERS 69
7.4 SOFTWARE & INFORMATICS 69
7.4.1 LABORATORY INFORMATION MANAGEMENT SYSTEM (LIMS) 70
7.4.2 ELECTRONIC LABORATORY NOTEBOOK (ELN) 70
7.4.3 LABORATORY EXECUTION SYSTEMS (LES) 70
7.4.4 SCIENTIFIC DATA MANAGEMENT SYSTEMS (SDMS) 71
8 GLOBAL LAB AUTOMATION MARKET, BY AUTOMATION TYPE 72
8.1 OVERVIEW 73
8.2 TOTAL LAB AUTOMATION 76
8.3 MODULAR AUTOMATION 76
9 GLOBAL LAB AUTOMATION MARKET, BY APPLICATION 77
9.1 OVERVIEW 78
9.2 CLINICAL DIAGNOSTICS 81
9.3 DRUG DISCOVERY 81
9.4 GENOMICS SOLUTIONS 81
9.5 PROTEOMIC SOLUTIONS 82
9.6 ANALYTICAL CHEMISTRY 82
9.7 PROTEIN ENGINEERING 83
9.8 BIO ANALYSIS 83
9.9 SYSTEM BIOLOGY 84
9.10 OTHERS 84
10 GLOBAL LAB AUTOMATION MARKET, BY END USER 86
10.1 OVERVIEW 87
10.2 BIOTECHNOLOGY & PHARMACEUTICALS 90
10.3 HOSPITALS & LABORATORIES 90
10.4 RESEARCH & ACADEMIC INSTITUTES 90
10.5 OTHERS 91
11 GLOBAL LAB AUTOMATION MARKET, BY REGION 92
11.1 OVERVIEW 93
11.2 NORTH AMERICA 98
11.2.1 U.S. 106
11.2.2 CANADA 109
11.2.3 MEXICO 113
11.3 EUROPE 117
11.3.1 GERMANY 125
11.3.2 FRANCE 128
11.3.3 U.K. 132
11.3.4 ITALY 136
11.3.5 RUSSIA 140
11.3.6 SPAIN 144
11.3.7 NETHERLANDS 147
11.3.8 SWITZERLAND 151
11.3.9 TURKEY 155
11.3.10 BELGIUM 159
11.3.11 REST OF EUROPE 163
11.4 ASIA-PACIFIC 164
11.4.1 CHINA 172
11.4.2 JAPAN 176
11.4.3 SOUTH KOREA 180
11.4.4 INDIA 184
11.4.5 AUSTRALIA 188
11.4.6 SINGAPORE 192
11.4.7 THAILAND 196
11.4.8 MALAYSIA 200
11.4.9 INDONESIA 204
11.4.10 PHILIPPINES 208
11.4.11 REST OF ASIA-PACIFIC 212
11.5 SOUTH AMERICA 213
11.5.1 BRAZIL 221
11.5.2 ARGENTINA 225
11.5.3 REST OF SOUTH AMERICA 229
11.6 MIDDLE EAST AND AFRICA 230
11.6.1 SOUTH AFRICA 238
11.6.2 SAUDI ARABIA 242
11.6.3 U.A.E. 246
11.6.4 REST OF MIDDLE EAST AND AFRICA 250
12 GLOBAL LAB AUTOMATION MARKET: COMPANY LANDSCAPE 251
12.1 COMPANY SHARE ANALYSIS: GLOBAL 251
12.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 252
12.3 COMPANY SHARE ANALYSIS: EUROPE 253
12.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 254
13 SWOT ANALYSIS 255
14 COMPANY PROFILE 256
14.1 THERMO FISHER SCIENTIFIC INC. 256
14.1.1 COMPANY SNAPSHOT 256
14.1.2 REVENUE ANALYSIS 257
14.1.3 COMPANY SHARE ANALYSIS 257
14.1.4 PRODUCT PORTFOLIO 257
14.1.5 RECENT DEVELOPMENTS 258
14.2 DANAHER 259
14.2.1 COMPANY SNAPSHOT 259
14.2.2 REVENUE ANALYSIS 259
14.2.3 COMPANY SHARE ANALYSIS 260
14.2.4 PRODUCT PORTFOLIO 260
14.2.5 RECENT DEVELOPMENTS 260
14.3 F. HOFFMANN- LA ROCHE LTD 261
14.3.1 COMPANY SNAPSHOT 261
14.3.2 REVENUE ANALYSIS 261
14.3.3 COMPANY SHARE ANALYSIS 262
14.3.4 PRODUCT PORTFOLIO 262
14.3.5 RECENT DEVELOPMENTS 262
14.4 PERKINELMER INC 264
14.4.1 COMPANY SNAPSHOT 264
14.4.2 REVENUE ANALYSIS 265
14.4.3 COMPANY SHARE ANALYSIS 265
14.4.4 PRODUCT PORTFOLIO 266
14.4.5 RECENT DEVELOPMENTS 266
14.5 BD 267
14.5.1 COMPANY SNAPSHOT 267
14.5.2 REVENUE ANALYSIS 267
14.5.3 COMPANY SHARE ANALYSIS 268
14.5.4 PRODUCT PORTFOLIO 268
14.5.5 RECENT DEVELOPMENTS 268
14.6 ABBOTT 269
14.6.1 COMPANY SNAPSHOT 269
14.6.2 REVENUE ANALYSIS 269
14.6.3 PRODUCT PORTFOLIO 270
14.6.3 RECENT DEVELOPMENTS 270
14.7 AGILENT TECHNOLOGIES 271
14.7.1 COMPANY SNAPSHOT 271
14.7.2 REVENUE ANALYSIS 271
14.7.3 PRODUCT PORTFOLIO 272
14.7.4 RECENT DEVELOPMENTS 272
14.8 AURORA BIOMED INC. 273
14.8.1 COMPANY SNAPSHOT 273
14.8.2 PRODUCT PORTFOLIO 273
14.8.3 RECENT DEVELOPMENTS 273
14.9 AZENTA US INC 274
14.9.1 COMPANY SNAPSHOT 274
14.9.2 REVENUE ANALYSIS 274
14.9.3 PRODUCT PORTFOLIO 275
14.9.4 RECENT DEVELOPMENTS 275
14.10 BIOMERIEUX 276
14.10.1 COMPANY SNAPSHOT 276
14.10.2 REVENUE ANALYSIS 276
14.10.3 PRODUCT PORTFOLIO 277
14.10.4 RECENT DEVELOPMENTS 277
14.11 EPPENDORF SE 278
14.11.1 COMPANY SNAPSHOT 278
14.11.2 PRODUCT PORTFOLIO 278
14.11.3 RECENT DEVELOPMENTS 278
14.12 HAMILTON COMPANY 279
14.12.1 COMPANY SNAPSHOT 279
14.12.2 PRODUCT PORTFOLIO 279
14.12.3 RECENT DEVELOPMENTS 279
14.13 HUDSON ROBOTICS 280
14.13.1 COMPANY SNAPSHOT 280
14.13.2 PRODUCT PORTFOLIO 280
14.13.3 RECENT DEVELOPMENTS 280
14.14 LABLYNX LIMS 281
14.14.1 COMPANY SNAPSHOT 281
14.14.2 PRODUCT PORTFOLIO 281
14.14.3 RECENT DEVELOPMENTS 281
14.15 LABVANTAGE SOLUTIONS INC. 282
14.15.1 COMPANY SNAPSHOT 282
14.15.2 PRODUCT PORTFOLIO 282
14.15.3 RECENT DEVELOPMENTS 282
14.16 LABWARE 283
14.16.1 COMPANY SNAPSHOT 283
14.16.2 PRODUCT PORTFOLIO 283
14.16.3 RECENT DEVELOPMENTS 283
14.17 QIAGEN 284
14.17.1 COMPANY SNAPSHOT 284
14.17.2 REVENUE ANALYSIS 284
14.17.3 PRODUCT PORTFOLIO 285
14.17.4 RECENT DEVELOPMENTS 285
14.18 SIEMENS HEALTHCARE GMBH 287
14.18.1 COMPANY SNAPSHOT 287
14.18.2 REVENUE ANALYSIS 287
14.18.3 PRODUCT PORTFOLIO 288
14.18.4 RECENT DEVELOPMENTS 288
14.19 TECAN TRADING AG 289
14.19.1 COMPANY SNAPSHOT 289
14.19.2 REVENUE ANALYSIS 289
14.19.3 PRODUCT PORTFOLIO 290
14.19.4 RECENT DEVELOPMENTS 290
15 QUESTIONNAIRE 291
16 RELATED REPORTS 294
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
